BRIEF published on 07/23/2024 at 17:57, 2 years ago GUERBET: Number of shares and voting rights as of June 30, 2024 Capital Actions AMF Guerbet Right To Vote
BRIEF published on 06/24/2024 at 12:06, 2 years 1 month ago GUERBET: Number of shares and voting rights as of May 31, 2024 Voting Rights Capital Actions AMF Guerbet
BRIEF published on 05/24/2024 at 17:50, 2 years 2 months ago Hugues Lecat Appointed Chairman of the Board of Directors at Guerbet AI Solutions Appointment Medical Imaging Hugues Lecat Guerbet Board
PRESS RELEASE published on 05/24/2024 at 17:45, 2 years 2 months ago Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet. Hugues Lecat appointed Chairman of the Board of Guerbet. Didier Izabel remains as a director. Strategic acceleration and innovative AI solutions in focus Guerbet Medical Imaging Chairman Of The Board Hugues Lecat Didier Izabel
BRIEF published on 05/21/2024 at 12:12, 2 years 2 months ago Number of Guerbet shares and voting rights as of April 30, 2024 Share Capital Voting Rights Actions Transparency Guerbet
BRIEF published on 03/20/2024 at 18:05, 2 years 4 months ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 2 years 4 months ago Guerbet: Change in Guerbet’s Board of Directors. Guerbet appoints Hugues Lecat as a non-voting director with plans for him to become Chairman, enhancing the company's governance and strategic vision for future success Board Of Directors Guerbet Medical Imaging Chairman Appointment Hugues Lecat
BRIEF published on 03/20/2024 at 17:50, 2 years 4 months ago Guerbet Announces Solid Growth and Improved Profitability in 2023 Full-Year Results Financial Results Profitability Guerbet Healthcare Imaging 2023 Growth
PRESS RELEASE published on 03/20/2024 at 17:45, 2 years 4 months ago Guerbet: 2023 full-year results. Guerbet publishes solid 2023 full-year results with revenue growth of 5.9% at CER and EBITDA margin exceeding target. Confirms outlook for 2024 with revenue growth > 8% and higher profitability Revenue Growth 2024 Outlook EBITDA Margin Guerbet 2023 Full-year Results
BRIEF published on 03/11/2024 at 08:05, 2 years 4 months ago Guerbet announces key appointments to boost its long-term strategy Innovation Appointments Guerbet Medical Imaging Long-term Strategy
Published on 08/01/2026 at 01:20, 2 days 7 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 7 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 8 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 9 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 08:30, 28 minutes ago Suspension - The Hospital Company (Dartford) Issuer PLC
Published on 08/03/2026 at 08:29, 29 minutes ago Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 07:00, 1 hour 58 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 11 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 13 hours ago Share retention commitments (Dutreil Agreement)
